Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P000053/S142

AMS 800 Artificial Urinary Sphincter (AUS)

Boston Scientific Corp · Decision date Sep 14, 2026

MEDTECHLEDGER EXPLANATIONP000053/S142

What did the FDA decide?

This 30-day notice for supplement S142 to PMA P000053 describes a manufacturing process change for the AMS 800 Artificial Urinary Sphincter. The stated change is the use of new kink resistant endcaps and process changes to accommodate those endcaps.

The notice does not state what the new endcaps are made of, how the process changes were validated, or whether the change affects device performance. The supplement type is a 30-day notice, not a new approval of the whole system, and the stated purpose is not independent proof of safety or clinical effectiveness.

FDA approval order statement

use of new kink resistant endcaps and process changes to accommodate those endcaps
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Gastroenterology, Urology
Decision date
Sep 14, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P000053/S142
Regulatory pathway
PMA supplement
Product code
EZY
Decision code
OK30
Decision date
Sep 14, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, incontinence, mechanical/hydraulic.

Product code
EZY
FDA device class
3

For the original device and its historical approval scope, see PMA P000053. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P000053 · Original PMA

    AMS SPHINCTER 800 URINARY CONTROL SYSTEM

  2. P000053/S142 received

    Application receipt date recorded by FDA.

  3. P000053/S142 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P000053. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P000053

Product / regulatory recordCompanyPathwayDecision dateSource
Boston Scientific CorpPMA approvalJun 14, 2001FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Boston Scientific Corp

Headquarters
Not reported
FDA applicant address
100 Boston Scientific Way, Marlboro, MA, 01752

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records